GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of endpoint — my 2-week log, condensed into one table — 67 comments in the full submission. View in context.
2.1k
c/trialwatch·submitted 3 months ago by u/yara_mensah

endpoint — my 2-week log, condensed into one table

Discussionbranch of 11 comments

Genuinely asking, not being difficult. Everyone in c/bloodwork repeats that SELECT is important. I believe it, but I have never seen anyone show why, and when I search I get 18 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it…

Read the full submission and all 67 comments →

This branch

11 comments, started 3 months ago
u/arne_ilunga45 points·3 months ago

the 16 week readout is different from the 20 week readout

replysharereportpermalink
u/curious_panel_only-16 points·3 months ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/tb500_tangent1 point·3 months ago

phase 2 is not phase 3, smaller n and shorter trial

Disagree on that part. 93.7% and 99.3% on the same vial is normal.

replysharereportpermalink
u/draw_up_dizzy1 point·3 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/first_hundred18 points·3 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/cold_chromatogram316 points·3 months ago

press release TRIUMPH posts must be flaired until a publication exists

replysharereportpermalink
u/anders_karlsen2 points·3 months ago

What was the dropout rate?

replysharereportpermalink
u/heart_rate_bump3 points·3 months ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
load more comments (3) →

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →